Investigación

Dianas farmacológicas en inflamación y enfermedades metabólicas

Buscador de publicaciones

Publicaciones

  • Toral M, Romero M, Jiménez R, Mahmoud AM, Barroso E, Gómez-Guzmán M, Sánchez M, Cogolludo Á, García-Redondo AB, Briones AM, Vazquez M, Pérez-Vizcaíno F and Duarte J.

    Carnitine palmitoyltransferase-1 up-regulation by PPAR-ß/d prevents lipid-induced endothelial dysfunction.

    CLIN SCI . 129(9): 823-837. Nº de citas: 38

    [doi:10.1042/CS20150111]

  • Magliano DC, Penna-de-Carvalho A, Vazquez M, Mandarim-de-Lacerda CA and Aguila MB.

    Short-term administration of GW501516 improves inflammatory state in white adipose tissue and liver damage in high-fructose-fed mice through modulation of the renin-angiotensin system.

    Endocrine . 50(2): 355-367. Nº de citas: 26

    [doi:10.1007/s12020-015-0590-1]

  • Palomer FX, Capdevila-Busquets E, Botteri G, Davidson MM, Rodríguez C, Martínez-González J, Vidal F, Barroso E, Chan TO, Feldman AM and Vazquez M.

    miR-146a targets Fos expression in human cardiac cells

    DISEASE MODELS & MECHANISMS . 8(9): 1081-1091. Nº de citas: 33

    [doi:10.1242/dmm.020768]

  • Petrov D, Pedrós I, Artiach G, Sureda FX, Barroso E, Pallàs M, Casadesús G, Beas-Zarate C, Carro E, Ferrer I, Vazquez M, Folch J and Camins A.

    High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1852(9): 1687-1699. Nº de citas: 125

    [doi:10.1016/j.bbadis.2015.05.004]

  • Salvadó L, Palomer FX, Barroso E and Vazquez M.

    Targeting endoplasmic reticulum stress in insulin resistance.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 26(8): 438-448. Nº de citas: 158

    [doi:10.1016/j.tem.2015.05.007]

  • Mitjans M, Catalán R, Vazquez M, González-Rodríguez A, Penadés R, Pons A, Massana G, Munro J, Arranz MJ and Arias B.

    Hypothalamic-pituitary-adrenal system, neurotrophic factors and clozapine response: association with FKBP5 and NTRK2 genes.

    PHARMACOGENET GENOM . 25(5): 274-277. Nº de citas: 16

    [doi:10.1097/FPC.0000000000000132]

  • Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Escoté X, Gómez-Serrano M, Peral B, Salvadó L, Fernández-Veledo S, Casals N, Vazquez M, Villarroya-Gombau F, Vendrell JJ, Serra D and Herrero L.

    Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.

    AM J PHYSIOL-ENDOC M . 308(9): . Nº de citas: 121

    [doi:10.1152/ajpendo.00362.2014]

  • Barroso E, Rodríguez-Rodríguez R, Chacón MR, Maymó-Masip E, Ferrer L, Salvadó L, Salmerón E, Wabistch M, Palomer FX, Vendrell J, Wahli W and Vazquez M.

    PPARß/d ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1852(5): 1049-1058. Nº de citas: 18

    [doi:10.1016/j.bbadis.2015.02.010]

  • Chehaibi K, Cedó L, Metso J, Palomer FX, Santos D, Quesada H, Naceur Slimane M, Wahli W, Julve J, Vazquez M, Jauhiainen M, Blanco-Vaca F and Escolà-Gil JC.

    PPAR-ß/d activation promotes phospholipid transfer protein expression.

    BIOCHEMICAL PHARMACOLOGY . 94(2): 101-108. Nº de citas: 20

    [doi:10.1016/j.bcp.2015.01.016]